BioScrip Inc Share Price Nasdaq
Stocks
US09069N1081
Healthcare Facilities & Services
| Market Cap | 4.74B 4.25B 3.89B 3.55B 6.68B 446B 6.89B 46.84B 18.68B 238B 17.8B 17.41B 751B | P/E 2026 * |
21.1x | P/E 2027 * | 18.6x |
|---|---|---|---|---|---|
| Enterprise Value | 5.62B 5.04B 4.61B 4.21B 7.93B 529B 8.18B 55.55B 22.15B 282B 21.1B 20.65B 890B | EV / Sales 2026 * |
0.98x | EV / Sales 2027 * | 0.9x |
| Free-Float |
79.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioScrip Inc
| 1 day | +6.86% |
| Manager | Title | Age | Since |
|---|---|---|---|
John Rademacher
CEO | Chief Executive Officer | 59 | 05/08/2019 |
Meenal Sethna
DFI | Director of Finance/CFO | 56 | 30/09/2025 |
Alyssa Moy
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
John Rademacher
BRD | Director/Board Member | 59 | 05/08/2019 |
Timothy Sullivan
BRD | Director/Board Member | 68 | 06/08/2019 |
R. Pate
BRD | Director/Board Member | 71 | 31/12/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.86% | +4.23% | - | - | 4.74B | |
| -2.46% | +4.61% | +5.01% | +114.28% | 103B | |
| +3.10% | -7.09% | +6.60% | +17.97% | 107B | |
| -14.59% | -25.01% | +56.52% | +620.81% | 45.05B | |
| +1.18% | +9.80% | +8.77% | +106.78% | 32.96B | |
| +0.90% | +1.43% | +48.63% | +74.94% | 29.77B | |
| +0.35% | +1.51% | +44.82% | +90.93% | 28.12B | |
| -1.09% | +3.69% | +38.76% | +418.82% | 22.55B | |
| +1.12% | -2.57% | -19.18% | -16.36% | 20.12B | |
| -0.26% | -1.91% | -6.33% | +28.12% | 16.76B | |
| Average | -0.49% | -1.92% | +20.40% | +161.81% | 45.11B | |
| Weighted average by Cap. | -1.16% | -2.61% | +17.61% | +146.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.76B 5.16B 4.72B 4.31B 8.12B 541B 8.37B 56.88B 22.68B 289B 21.61B 21.15B 912B | 6.13B 5.49B 5.02B 4.58B 8.64B 576B 8.91B 60.53B 24.14B 307B 22.99B 22.5B 970B |
| Net income | 226M 202M 185M 169M 318M 21.2B 328M 2.23B 888M 11.31B 846M 828M 35.71B | 252M 226M 207M 189M 356M 23.73B 367M 2.49B 994M 12.66B 947M 927M 39.97B |
| Net Debt | 881M 791M 723M 660M 1.24B 82.86B 1.28B 8.71B 3.47B 44.21B 3.31B 3.24B 140B | 761M 682M 624M 569M 1.07B 71.5B 1.11B 7.52B 3B 38.15B 2.86B 2.79B 120B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
